Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 74

    AstraZeneca new drugs including Tagrisso, Lynparza boost Q3 product sales

    AstraZeneca new drugs including Tagrisso, Lynparza boost Q3 product sales

    Medical Dialogues Bureau26 Oct 2019 9:30 AM IST
    New Delhi: AstraZeneca Plc reported better-than-expected third-quarter product sales on Thursday, on the back of strong demand for newer medicines...
    Abbott, Australian Blood Service ink agreement for Alinity System

    Abbott, Australian Blood Service ink agreement for Alinity System

    Medical Dialogues Bureau26 Oct 2019 9:15 AM IST
    New Delhi: Abbott recently announced the Australian Red Cross Blood Service (Australian Blood Service) has signed a multiple-year agreement for...
    Crown Bioscience launches patient-derived tumour organoid drug development platform

    Crown Bioscience launches patient-derived tumour organoid drug development platform

    Medical Dialogues Bureau26 Oct 2019 9:00 AM IST
    New Delhi: Crown Bioscience recently announced the launch of a new tumour organoid drug development platform with the potential to significantly...
    Alembic Pharma JV gets USFDA approval for Desonide Ointment to treat skin diseases

    Alembic Pharma JV gets USFDA approval for Desonide Ointment to treat skin diseases

    Medical Dialogues Bureau25 Oct 2019 11:45 AM IST
    Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of...
    New batch of Strides Pharma Ranitidine available for sale in Australia

    New batch of Strides Pharma Ranitidine available for sale in Australia

    Medical Dialogues Bureau25 Oct 2019 11:33 AM IST
    Out of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have an NDMA level at or above the acceptable limit of 0.3...
    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Medical Dialogues Bureau25 Oct 2019 11:32 AM IST
    Haloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
    Major US retailers including Walmart pull bottles of JnJ baby powder from shelves

    Major US retailers including Walmart pull bottles of JnJ baby powder from shelves

    Medical Dialogues Bureau25 Oct 2019 9:17 AM IST
    Late Thursday, CNBC reported that Walmart, the world's largest retailer, had also removed and blocked all of the recalled Johnson's baby powder (JnJ...
    Reckitt Benckiser to pay USD 700 million to settle opioid probes

    Reckitt Benckiser to pay USD 700 million to settle opioid probes

    Medical Dialogues Bureau25 Oct 2019 9:15 AM IST
    Reckitt Benckiser in July agreed to pay up to $1.4 billion to resolve the U.S. claims that its former pharmaceuticals business Indivior before it was...
    Drug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality; Details

    Drug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality; Details

    Farhat Nasim24 Oct 2019 2:22 PM IST
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 28 drugs made by certain...
    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    Medical Dialogues Bureau24 Oct 2019 10:00 AM IST
    Zejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
    Strides Pharma clears USFDA inspection of Alathur facility

    Strides Pharma clears USFDA inspection of Alathur facility

    Medical Dialogues Bureau24 Oct 2019 9:45 AM IST
    Strides Pharma said in a filing, the company's formulations unit in Alathur was inspected by the US Food and Drug Administration (USFDA) in August...
    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Medical Dialogues Bureau24 Oct 2019 9:30 AM IST
    This recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
    PrevNext

    Popular Stories

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok